Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Recent Patents on Biotechnology
  4. Volume 19, Issue 3
  5. Article
  • ISSN: 1872-2083
  • E-ISSN: 2212-4012

Abstract

Background

Diabetic peripheral neuropathy (DPN) is a complication of diabetes that occurs in 40 - 60 million individuals worldwide and is associated with other chronic diseases. However, there are no review studies that present the state-of- the- art and technologies developed to circumvent this important health problem.

Materials and Methods

This review was conducted based on scientific papers and patents. The papers were retrieved from Lilacs, PubMed, and Web of Science databases, and the patents from INPI, ESPACENET, WIPO, and GOOGLE PATENTS. Thus, a sample consisting of 14 scientific articles and 667 patents was analyzed.

Results

From the analysis of the data, we drew an overview of the development of biomedical technologies for DPN and detected the pioneering spirit of China, the USA, and Japan in the area, with a focus on the treatment of DPN. Based on this, we carried out a SWOT analysis to help direct future efforts in the area, which should focus primarily on developing technologies for prevention, early diagnosis, and, above all, cure of the disease to reduce the important impact of this disease in various sectors of society.

Conclusion

This study finds a concentration of diabetic peripheral neuropathy products, especially therapeutic drugs, in high-income countries. It highlights the need for global collaboration and strategic focus on therapeutic adherence and preventive strategies to effectively manage DPN.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/biot/10.2174/0118722083314714240820115610
2024-08-27
2025-04-15

  • From This Site

    /content/journals/biot/10.2174/0118722083314714240820115610
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. YuY. Gold Standard for Diagnosis of DPN.Front. Endocrinol.20211271935610.3389/fendo.2021.719356 34764937
     [Google Scholar]
  2. Pop-BusuiR. AngL. BoultonA.J. Diagnosis and treatment of painful diabetic peripheral neuropathy.Arlington, (VA)Am Diabetes Associat202213210.2337/db2022‑01
     [Google Scholar]
  3. ChitneniA. RuppA. GhorayebJ. Abd-ElsayedA. Early detection of diabetic peripheral neuropathy by fMRI: An evidence-based review.Brain Sci.202212555710.3390/brainsci12050557 35624944
     [Google Scholar]
  4. RolimL.T.P. FlumignanR. Diagnstico e tratamento da neuropatia perifrica diabtica.Conectando Pessoas2022
     [Google Scholar]
  5. ZhuJ. HuZ. LuoY. Diabetic peripheral neuropathy: Pathogenetic mechanisms and treatment.Front. Endocrinol. (Lausanne)202414126537210.3389/fendo.2023.1265372 38264279
     [Google Scholar]
  6. ChakrabortyS. MajumderA. Prevalence and correlates of peripheral neuropathy amongst type 2 diabetes mellitus patients – A community based epidemiological study in a town of eastern India.J Med Evid20234213013510.4103/JME.JME_26_22
     [Google Scholar]
  7. GandhiM. FargoE. Prasad-ReddyL. MahoneyK.M. IsaacsD. Diabetes: How to manage diabetic peripheral neuropathy.Drugs Context20221111310.7573/dic.2021‑10‑2 35775075
     [Google Scholar]
  8. FanR.R. GibsonA.K. SmedsM.R. ZakharyE. Impact of socioeconomic status on major amputation in patients with peripheral vascular disease and diabetes mellitus.Ann. Vasc. Surg.202287788610.1016/j.avsg.2022.03.035 35398196
     [Google Scholar]
  9. HaJ.H. JinH. ParkJ.U. Association between socioeconomic position and diabetic foot ulcer outcomes: A population-based cohort study in South Korea.BMC Public Health2021211139510.1186/s12889‑021‑11406‑3 34261483
     [Google Scholar]
  10. TatulashviliS. FagherazziG. DowC. CohenR. FosseS. BihanH. Socioeconomic inequalities and type 2 diabetes complications: A systematic review.Diabetes Metab.2020462899910.1016/j.diabet.2019.11.001 31759171
     [Google Scholar]
  11. CfO. Transforming our world: the 2030 Agenda for Sustainable Development.New York, NY, USAUnited Nations2015
     [Google Scholar]
  12. LinC-R. ChangW-H. Welcome to develop, advance and innovate the health technology.Health Technol. (Berl.)201711
     [Google Scholar]
  13. LiaropoulosL. Letter to the Editor.Int. J. Technol. Assess. Health Care199713112512710.1017/S0266462300010291 9119620
     [Google Scholar]
  14. AbbasA. ZhangL. KhanS.U. A literature review on the state-of-the-art in patent analysis.World Pat. Inf.20143731310.1016/j.wpi.2013.12.006
     [Google Scholar]
  15. TavakoliM. KlingelhAfer D, Fadavi H, Groneberg DA. The landscape of global research on diabetic neuropathy.Front. Endocrinol. (Lausanne)202314122089610.3389/fendo.2023.1220896 38034004
     [Google Scholar]
  16. NiL. ChenX. GongX. Patent information analysis of TCM prescription for the treatment of diabetes based on patent analysis and SWOT model.Phytomedicine Plus20222310030710.1016/j.phyplu.2022.100307
     [Google Scholar]
  17. LuY. XingP. CaiX. Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: Estimates of the INTERPRET-DD study.Front. Public Health2020853437210.3389/fpubh.2020.534372 33194943
     [Google Scholar]
  18. LiC. WangW. JiQ. Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China.Diabetes Res. Clin. Pract.202319811060210.1016/j.diabres.2023.110602 36871876
     [Google Scholar]
  19. Yovera-AldanaM. Velásquez-RimachiV. Huerta-RosarioA. Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: A systematic review and meta-analysis.PLoS One2021165e025164210.1371/journal.pone.0251642 33984049
     [Google Scholar]
  20. AsoY. Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches.J. Diabetes Investig.202213343243410.1111/jdi.13711 34779155
     [Google Scholar]
  21. CarmichaelJ. FadaviH. IshibashiF. ShoreA.C. TavakoliM. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy.Front. Endocrinol. (Lausanne)20211267125710.3389/fendo.2021.671257 34122344
     [Google Scholar]
  22. GoudaH.N. CharlsonF. SorsdahlK. Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: Results from the Global Burden of Disease Study 2017.Lancet Glob. Health2019710e1375e138710.1016/S2214‑109X(19)30374‑2 31537368
     [Google Scholar]
  23. VolmanB. Direct costs and availability of diabetes medicines in low-income and middle-income countries.WHO2008
     [Google Scholar]
  24. KiyaniM. YangZ. CharalambousL.T. Painful diabetic peripheral neuropathy.Neurol. Clin. Pract.2020101475710.1212/CPJ.0000000000000671 32190420
     [Google Scholar]
  25. LuB. YangZ. WangM. High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.Diabetes Res. Clin. Pract.201088328929410.1016/j.diabres.2010.02.002 20359765
     [Google Scholar]
  26. LinY.K. GaoB. LiuL. The prevalence of diabetic microvascular complications in China and the USA.Curr. Diab. Rep.20212161610.1007/s11892‑021‑01387‑3 33835284
     [Google Scholar]
  27. BAnhofGJ HerderC StromA PapanasN RodenM ZieglerD Emerging biomarkers, tools, and treatments for diabetic polyneuropathy.Endocr. Rev.201940115319210.1210/er.2018‑00107 30256929
     [Google Scholar]
  28. DuS.H. ZhengY.L. ZhangY.H. WangM.W. WangX.Q. The last decade publications on diabetic peripheral neuropathic pain: A bibliometric analysis.Front. Mol. Neurosci.20221585400010.3389/fnmol.2022.854000 35493329
     [Google Scholar]
  29. HicksC.W. SelvinE. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes.Curr. Diab. Rep.201919108610.1007/s11892‑019‑1212‑8 31456118
     [Google Scholar]
  30. NawratA. China in 2019: A prime destination for pharma R D deals.2019Available from: https://www.pharmaceutical-technology.com/features/china-rd-deals-trends-2019/ (accessed on 15-7-2024)
  31. TanY. China’s diaspora engagement policy and its powerful effect outside its borders.Melbourne Asia Review2021
     [Google Scholar]
  32. ZamorinV. Participation of the chinese military-industrial complex in the implementation of the state plan “Made in China - 2025”.Problematic Dalnego Vostoka202320232105121
     [Google Scholar]
  33. XiaoL. ZhangY. An analysis on the policy evolution of cross-border ecommerce industry in China from the perspective of sustainability.Electron. Commerce Res.202222387589910.1007/s10660‑020‑09427‑y
     [Google Scholar]
  34. DuM. Cross-BorderM. Cross-Border MA performance of Chinese enterprises in the context of the belt and road initiative.Chinese Political Science Review20216222825010.1007/s41111‑020‑00173‑y
     [Google Scholar]
  35. IP5 Statistics Report 2019 Edition.2019Available from: https://www.fiveipoffices.org/statistics/statisticsreports/2019edition (accessed on 19-7-2024)
  36. Accelerated examination and speedy grants in China.2023Available from: https://www.epo.org/searching-for-patents/helpful-resources/patentknowledge-news/2023/20230327a.html (accessed on 19-7-2024)
  37. Patent process overview.2023Available from: https://www.uspto.gov/patents/basics/patent-process-overview#step3 (accessed on 19-7-2024)
  38. Patent2023Available from: https://www.jpo.go.jp/e/faq/yokuaru/patent.html (accessed on 19-7-2024)
  39. ZhuW. HuangW. XuZ. Analysis of patents issued in China for antihyperglycemic therapies for type 2 diabetes mellitus.Front. Pharmacol.20191058610.3389/fphar.2019.00586 31214029
     [Google Scholar]
  40. World Intellectual Property Indicators 2021.2021Available from: https://www.wipo.int/edocs/pubdocs/en/wipo_pub_941_2021.pdf (accessed on 19-7-2024)
  41. World Intellectual Property Indicators 2022.2022Available from: https://www.wipo.int/edocs/pubdocs/en/wipo-pub-941-2022-en-worldintellectual-property-indicators-2022.pdf (accessed on 19-7-2024)
  42. China's 14th Five-Year Plan: Transforming China into an Industrial and Technological Powerhouse.2021Available from: https://iedi.org.br/cartas/carta_iedi_n_1094.html (accessed on 19-7-2024)
  43. HeZ.L. TongT.W. ZhangY. HeW. A database linking Chinese patents to China’s census firms.Scientific Data201851180042
     [Google Scholar]
  44. LiY. PhelpsN.A. LiuZ. MaH. The landscape of Chinese invention patents: Quantity, density, and intensity.Environ Planning A: Eco Space2019514823826
     [Google Scholar]
  45. Guia de investimento na China.2021Available from: http://bdco.com.br/wp-content/uploads/2021/09/BDCo-Guia-de-Investimento_link.pdf (accessed on 19-7-2024)
  46. TanR.Y.R. Patented in China.Undergrad Res J Humanities201831678110.17161/1808.26395
     [Google Scholar]
  47. YangK. WangY. LiY. Progress in the treatment of diabetic peripheral neuropathy.Biomed. Pharmacother.202214811271710.1016/j.biopha.2022.112717 35193039
     [Google Scholar]
  48. AcioliG. JúniorA.O. Prospecção tecnológica sobre a cura do diabetes mellitus.Revista Geintec-Gestao Inovacao e Tecnologias.20144412991307
     [Google Scholar]
  49. QureshiZ. AliM.N. KhalidM. An insight into potential pharmacotherapeutic agents for painful diabetic neuropathy.J. Diabetes Res.2022202211910.1155/2022/9989272 35127954
     [Google Scholar]
  50. ChuteC. FrenchT. Introducing care 4.0: an integrated care paradigm built on industry 4.0 capabilities.Int. J. Environ. Res. Public Health20191612224710.3390/ijerph16122247 31242687
     [Google Scholar]
  51. PiaggioD. CastaldoR. GaribizzoG. IadanzaE. PecchiaL. A smartphone-based tool for screening diabetic neuropathies: A mHealth and 3D printing approach.Biomed. Signal Process. Control20248910580710.1016/j.bspc.2023.105807
     [Google Scholar]
  52. ZieglerD. PapanasN. SchnellO. Current concepts in the management of diabetic polyneuropathy.J. Diabetes Investig.202112446447510.1111/jdi.13401 32918837
     [Google Scholar]
  53. YangW. YuX. WangD. YangJ. ZhangB. Spatio-temporal evolution of technology flows in China: Patent licensing networks 2000-2017.J. Technol. Transf.20214651674170310.1007/s10961‑019‑09739‑8
     [Google Scholar]
  54. Traditional Chinese medicine formula treating diabetic peripheral neuropathy.Patent CN104510806A2013
  55. PangH. LinC. QinX. An analysis of patent application for tcm intervention treatment of immune diseases-Take China and Guangdong province patent as an example.J. Phys. Conf. Ser.20201624202202810.1088/1742‑6596/1624/2/022028
     [Google Scholar]
  56. BarrosG.S. PereiraH.H.C.S. SouzaM.S.R. CamargoM.E. MenezesP.P. SilvaG.F. Mapping of patents related to the development of products for diabetic neuropathy: A technological prospection from 2010 to 2022.Res Soc Develop2022116e1731162902210.33448/rsd‑v11i6.29022
     [Google Scholar]
  57. BaryakovaT.H. PogostinB.H. LangerR. McHughK.J. Overcoming barriers to patient adherence: The case for developing innovative drug delivery systems.Nat. Rev. Drug Discov.202322538740910.1038/s41573‑023‑00670‑0 36973491
     [Google Scholar]
  58. AbramsonA. Caffarel-SalvadorE. KhangM. An ingestible self-orienting system for oral delivery of macromolecules.Science2019363642761161510.1126/science.aau2277 30733413
     [Google Scholar]
  59. MahakiB. BahadoriM. RaadabadiM. RavangardR. The barriers to the application of the research findings from the nurses’ perspective: A case study in a teaching hospital.J. Educ. Health Promot.2016511410.4103/2277‑9531.184553 27500167
     [Google Scholar]
  60. Abu-OdahH. SaidN.B. NairS.C. Identifying barriers and facilitators of translating research evidence into clinical practice: A systematic review of reviews.Health Soc. Care Community2022306e3265e327610.1111/hsc.13898 35775332
     [Google Scholar]
  61. YangH. SloanG. YeY. New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine.Front. Endocrinol.20201092910.3389/fendo.2019.00929 32010062
     [Google Scholar]
  62. Al-TabbaaO. NeneA. Heterogeneous Inter-Organizational Social Capital in University-Industry Collaboration for Technology Transfer.University-Industry Collaboration Strategies in the Digital Era.Hershey, PA, USAIGI Global202130132010.4018/978‑1‑7998‑3901‑9.ch015
     [Google Scholar]
  63. DanielA.D. AlvesL. University-industry technology transfer: the commercialization of university’s patents.Knowl. Manag. Res. Pract.202018327629610.1080/14778238.2019.1638741
     [Google Scholar]
  64. LavertyH. MeulienP. The innovative medicines initiative - 10 years of public-private collaboration.Front. Med.2019627510.3389/fmed.2019.00275 31850354
     [Google Scholar]
  65. BoycottK.M. LauL.P.L. CutilloC.M. AustinC.P. International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases.EMBO Mol. Med.2019115e1048610.15252/emmm.201910486 30979709
     [Google Scholar]
  66. MouraE.G. Camargo Junior KRd. A crise no financiamento da pesquisa e pós-graduação no Brasil.Cad. Saude Publica2017201733
     [Google Scholar]
  67. SachettiC.G. JúniorA.B. de CarvalhoA.C.C. Angulo-TuestaA. da SilvaE.N. Landscape of Brazilian research and development public funding in advanced therapies: Lessons learned and a roadmap for middle-income economies.Cytotherapy202224111158116510.1016/j.jcyt.2022.06.004 35945103
     [Google Scholar]
/content/journals/biot/10.2174/0118722083314714240820115610
Loading
The Landscape of Products for Diabetic Peripheral Neuropathy: A Scientific and Patent Systematic Review
Recent Pat. Biotechnol. 19, 221 (2025); https://doi.org/10.2174/0118722083314714240820115610
/content/journals/biot/10.2174/0118722083314714240820115610
/content/journals/biot/10.2174/0118722083314714240820115610
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): Biomedical technology; diabetic peripheral neuropathy; high-income countries; patent; review studies; SWOT analysis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test